AMBALAL SARABHAI ENTERPRISES
|
AMBALAL SARABHAI ENTERPRISES Last 5 Year Financial Ratios History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Operational & Financial Ratios | |||||
| Earnings Per Share (Rs) | 0.64 | 0.74 | 1.49 | 6.16 | 3.83 |
| CEPS(Rs) | 1.17 | 1.21 | 1.85 | 6.46 | 4.15 |
| DPS(Rs) | - | - | - | - | - |
| Book NAV/Share(Rs) | 18.27 | 17.80 | 17.08 | 15.64 | 9.64 |
| Tax Rate(%) | -2.03 | 14.59 | 24.55 | 12.87 | 9.79 |
| Margin Ratios | |||||
| Core EBITDA Margin(%) | 4.27 | 4.81 | 5.04 | 12.50 | -0.92 |
| EBIT Margin(%) | 4.77 | 7.08 | 10.20 | 27.86 | 21.39 |
| Pre Tax Margin(%) | 2.40 | 3.70 | 8.65 | 26.85 | 19.47 |
| PAT Margin (%) | 2.44 | 3.16 | 6.53 | 23.39 | 17.57 |
| Cash Profit Margin (%) | 4.43 | 5.15 | 8.10 | 24.54 | 19.01 |
| Performance Ratios | |||||
| ROA(%) | 1.91 | 2.29 | 4.81 | 21.57 | 15.02 |
| ROE(%) | 3.57 | 4.25 | 9.13 | 48.74 | 49.47 |
| ROCE(%) | 5.20 | 7.16 | 11.18 | 45.53 | 40.28 |
| Asset Turnover(x) | 0.78 | 0.73 | 0.74 | 0.92 | 0.86 |
| Sales/Fixed Asset(x) | 1.85 | 1.71 | 2.02 | 2.89 | 2.44 |
| Working Capital/Sales(x) | -104.96 | 11.09 | 21.73 | 13.71 | -21.02 |
| Efficiency Ratios | |||||
| Fixed Capital/Sales(x) | 0.54 | 0.58 | 0.49 | 0.35 | 0.41 |
| Receivable days | 63.69 | 54.38 | 57.66 | 60.46 | 73.84 |
| Inventory Days | 36.01 | 34.09 | 33.90 | 28.13 | 35.41 |
| Payable days | 137.23 | 132.85 | 149.28 | 155.45 | 165.09 |
| Valuation Parameters | |||||
| PER(x) | 54.47 | 61.35 | 13.73 | 5.66 | 4.61 |
| PCE(x) | 30.05 | 37.66 | 11.07 | 5.40 | 4.26 |
| Price/Book(x) | 1.92 | 2.55 | 1.20 | 2.23 | 1.83 |
| Yield(%) | - | - | - | - | - |
| EV/Net Sales(x) | 1.56 | 2.08 | 1.01 | 1.35 | 0.80 |
| EV/Core EBITDA(x) | 15.29 | 18.96 | 8.09 | 3.94 | 4.53 |
| EV/EBIT(x) | 31.76 | 28.31 | 9.65 | 4.71 | 3.68 |
| EV/CE(x) | 1.62 | 1.99 | 0.99 | 1.15 | 0.63 |
| M Cap / Sales | 1.37 | 2.01 | 0.92 | 1.36 | 0.83 |
| Growth Ratio | |||||
| Net Sales Growth(%) | 13.03 | 1.93 | -13.45 | 20.23 | 22.58 |
| Core EBITDA Growth(%) | 5.07 | -10.80 | -68.28 | 131.58 | 29.13 |
| EBIT Growth(%) | -24.46 | -28.75 | -68.20 | 57.35 | 79.39 |
| PAT Growth(%) | -13.18 | -50.38 | -75.76 | 60.86 | 90.17 |
| EPS Growth(%) | -13.20 | -50.38 | -75.76 | 60.85 | 108.76 |
| Financial Stability Ratios | |||||
| Total Debt/Equity(x) | 0.35 | 0.33 | 0.33 | 0.21 | 0.37 |
| Current Ratio(x) | 0.98 | 1.16 | 1.08 | 1.14 | 0.94 |
| Quick Ratio(x) | 0.79 | 1.00 | 0.91 | 1.00 | 0.81 |
| Interest Cover(x) | 2.01 | 2.09 | 6.60 | 27.54 | 11.17 |
| Total Debt/Mcap(x) | 0.18 | 0.13 | 0.28 | 0.10 | 0.20 |
Compare Financial Ratios of peers of AMBALAL SARABHAI ENTERPRISES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| AMBALAL SARABHAI ENTERPRISES | ₹273.8 Cr | -0.5% | -1% | -49.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹406,267.0 Cr | 0.7% | 2.8% | 7.9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹178,672.0 Cr | -0.8% | 3.7% | 48.6% | Stock Analytics | |
| CIPLA | ₹119,713.0 Cr | -0.2% | -0.1% | -1.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹119,195.0 Cr | 3.4% | 11.2% | 17.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹104,999.0 Cr | 0.6% | -5.2% | -4.9% | Stock Analytics | |
AMBALAL SARABHAI ENTERPRISES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| AMBALAL SARABHAI ENTERPRISES | -0.5% |
-1% |
-49.8% |
| SENSEX | -0.9% |
0.4% |
1.4% |
You may also like the below Video Courses
